# Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy

> **NCT02990936** · — · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire UCLouvain Namur** · enrollment: 120 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Tumor Growth

## Interventions

- **OTHER:** Tumor delineation

## Key facts

- **NCT ID:** NCT02990936
- **Lead sponsor:** Centre Hospitalier Universitaire UCLouvain Namur
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2019-11-01
- **Primary completion:** 2024-11
- **Final completion:** 2026-11
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02990936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02990936, "Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02990936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*